Centre Hospitalier de Wallonie Picarde - Site Notre Dame
About Centre Hospitalier de Wallonie Picarde - Site Notre Dame
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Clinical Trials at Centre Hospitalier de Wallonie Picarde - Site Notre Dame
During the past decade, Centre Hospitalier de Wallonie Picarde - Site Notre Dame conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-10-19
2025-03-18
Active, not recruiting
1,177
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
2021-03-22
2022-08-09
Terminated
81
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame"
#1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centre Hospitalier de Wallonie Picarde - Site Notre Dame
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame" are
"Ulcerative Colitis" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier de Wallonie Picarde - Site Notre Dame
Most popular intervention types in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "LY3471851" (1 trials), "Mirikizumab" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier de Wallonie Picarde - Site Notre Dame
The vast majority of trials in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame" are
3 trials for "All" genders.
Clinical Trials Status at Centre Hospitalier de Wallonie Picarde - Site Notre Dame
Currently, there are NaN active trials in "Centre Hospitalier de Wallonie Picarde - Site Notre Dame".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centre Hospitalier de Wallonie Picarde - Site Notre Dame,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier de Wallonie Picarde - Site Notre Dame, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".